Curtis Oltmans

Chief Legal Officer at Fulcrum Therapeutics

Curtis Oltmans, JD joined Fulcrum as General Counsel in November 2020 with over 25 years of experience in corporate law including senior management positions in legal departments at several leading pharmaceutical and biotechnology companies. He most recently served as Vice President, Head of Litigation at DaVita Kidney Care, Inc. where he led a 30-person team and was responsible for all litigation, workers’ compensation and employee safety matters. Prior to DaVita, Curtis was Executive Vice President, General Counsel and Corporate Secretary at Array BioPharma Inc. where he oversaw all legal, corporate governance, patent and compliance matters. He previously served as Corporate Vice President and General Counsel for Novo Nordisk, Inc., North America where he was responsible for strategic support in areas including market access, government affairs, communications and product marketing. He has also served as Assistant General Counsel for Eli Lilly and Company after beginning his legal career supporting clients in pharmaceutical and medical device litigation matters. Curtis received a BA in political science from the University of Nebraska and his JD from the University of Nebraska College of Law.

Location

Boulder, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Fulcrum Therapeutics

2 followers

Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases.


Employees

51-200

Links